The Canadian Bioceutical Corporation announced that Randall (Randy) Stafford has been named Chief Financial Officer, replacing Donald Stott, effective December 1, 2016. In a career spanning over three decades, Mr. Stafford has held a variety of senior financial and operational positions and has a deep understanding of the interplay between finance and commercial development. Prior to joining BCC, he served as Vice President of Finance at Cushman & Wakefield Canada, a large international service provider to the commercial real estate sector.

While at Cushman & Wakefield, he played a key role in the Company's strategic planning and budgeting and the overall management of financial and operational functions. BCC also announced the appointment of Jonathan Chu as its Vice President of Finance and Accounting. Mr. Chu has a strong track record in financial management, having held various senior positions, such as Acting Chief Financial Officer at EnerGulf Resources, Senior Financial Analyst at Marrelli Support Services, and a Senior Staff Accountant at Resnick & Company, LLP.

Both Mr. Stafford and Mr. Chu will be based in BCC's Toronto offices.